What is HERmd?
Founded in 2015 and headquartered in Cincinnati, Ohio, HERmd operates as a comprehensive healthcare provider dedicated to addressing the unique medical needs of women. The company distinguishes itself through a hybrid delivery model that seamlessly integrates in-person clinical visits with virtual care options, ensuring that patients receive consistent, high-quality support. Beyond direct-to-consumer services, HERmd has expanded its operational footprint into the enterprise sector, offering tailored health benefits to corporations. This B2B strategy allows employers to provide their workforce and families with streamlined access to specialized care, including efficient prescription management and holistic wellness resources, thereby positioning HERmd as a critical player in the modern health benefits ecosystem.
How much funding has HERmd raised?
HERmd has raised a total of $40M across 1 funding round:
Series A
$40M
Series A (2022): $40M with participation from JAZZ Venture Partners
Key Investors in HERmd
JAZZ Venture Partners
JAZZ Venture Partners is a venture capital firm that invests in technologies aimed at enhancing human performance across various sectors, including healthcare, wellness, and consumer markets. The firm collaborates with early and growth-stage companies to drive innovation at the intersection of technology, science, and humanity.
What's next for HERmd?
With the infusion of this major enterprise-level funding, HERmd is poised to accelerate its national expansion and enhance its technological infrastructure. The strategic roadmap likely involves scaling its physical clinic footprint while simultaneously optimizing its digital health platform to support a larger volume of enterprise partnerships. By leveraging this capital, the company aims to deepen its impact on health equity and patient outcomes, potentially exploring new service lines or diagnostic capabilities. As the demand for specialized, accessible women's health services continues to rise, HERmd's ability to execute on its hybrid care strategy will be instrumental in maintaining its competitive advantage and driving long-term value for both patients and corporate stakeholders.
See full HERmd company page
